| Identification | Back Directory | [Name]
Cyclopropanamine, 2-(2,3-difluorophenyl)-, (1R,2S)- | [CAS]
1427524-53-5 | [Synonyms]
(1R,2S)-2-(2,3-Difluorophenyl)cyclopropylamine
Cyclopropanamine, 2-(2,3-difluorophenyl)-, (1R,2S)- | [Molecular Formula]
C9H9F2N | [MDL Number]
MFCD28390211 | [MOL File]
1427524-53-5.mol | [Molecular Weight]
169.17 |
| Chemical Properties | Back Directory | [Boiling point ]
195.1±40.0 °C(Predicted) | [density ]
1.268±0.06 g/cm3(Predicted) | [pka]
8.05±0.20(Predicted) | [InChI]
InChI=1S/C9H9F2N/c10-7-3-1-2-5(9(7)11)6-4-8(6)12/h1-3,6,8H,4,12H2/t6-,8+/m0/s1 | [InChIKey]
MCABSRDMAUTFDE-POYBYMJQSA-N | [SMILES]
[C@@H]1(N)C[C@H]1C1=CC=CC(F)=C1F |
| Hazard Information | Back Directory | [Uses]
(1R,2S)-2-(2,3-dDifluorophenyl)cyclopropanamine D-Mandelic Acid, is used in the synthesis of Ticagrelor (T437700), which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS). |
|
|